Leptin has recently been shown to play a role in metabolic reprogramming in breast cancer cells, consisting of an enhanced use of glucose for biosynthesis and lipids for energy production, as a result of the increased demands of energy and biosynthetic intermediates to sustain proliferation and invasion [27]. The gene discussed is LEP; the disease is breast carcinoma.